In a notable move aimed at curbing fraud in scientific publications, the journal Science said last week that it will probably begin targeting certain "high-risk" papers for extra scrutiny.
The move comes in response to a report from an external committee convened by the journal to assess its handling of the papers behind the Woo Suk Hwang fraud scandal. And it turns on its head -for a handful of papers at least -the traditional presumption that manuscripts submitted to a journal are researched and written honestly.
"Until now, it has been assumed as a default that scientists are honest. The burden of proof is to show that they are not. Now, at least for a select number of papers where the risk factor is high, there is a new burden, to show that these papers are honest, " says Sheldon Krimsky, a bioethicist at Tufts University in Medford, Massachusetts.
Hwang, a South Korean researcher working at Seoul National University, published highprofile papers in Science 1,2 in 2004 and 2005 that claimed to have generated embryonic stem cells by somatic-cell nuclear transfer. This is a key step to generating replacement tissues from a patient's own cells. Both papers turned out to have been fabricated, and Science retracted them in January 3 . The review committee, headed by John Brauman, a chemist at Stanford University in California, released its report into Science's conduct last week. Although Science had followed high-standard editorial procedures "with exceptional care" in the Hwang case, Brauman says, "we suggested that the journal institute a policy we describe as risk assessment" in an effort to clamp down on fraud.
Writing in an editorial 4 , Science's editor-inchief Donald Kennedy said that the journal is now developing criteria for deciding which papers deserve particularly careful scrutiny. "Papers that are of substantial public interest, present results that are unexpected and/or counterintuitive, or touch on areas of high political controversy may fall into this category, " he wrote.
Such papers, perhaps ten a year, would receive "special attention" that could include greater requirements for including primary data and more intensive evaluation of digital images. The journal would also demand explicit descriptions of each author's contribution to a paper.
Even as Kennedy announced the plans, Science reported doubts about the results of another high-profile paper it recently published in a controversial area of developmental biology. Pending the outcome of an investigation by the University of Missouri, Columbia, this will also probably be retracted.
In a paper 5 that sparked debate from the moment it was published, R. Michael Roberts and colleagues, researchers at the university, claimed that mouse embryonic cells have distinct developmental fates from the first cell division onwards. This flies in the face of the broadly held view that in mammals such cells can still develop into any cell in the body. The paper was published on 17 February this year, and the university launched an investigation in April that is still continuing.
Kennedy cautioned in a press briefing that the social costs associated with loss of trust among scientists might be greater than those of the occasional retraction. But he said he would collaborate with Nature and other journals to draw up a common set of standards aimed at deterring fraud. Philip Campbell, Nature's editor-in-chief, declined to comment in detail on the committee's findings, but said: "We at Nature welcome the external review conducted by Science and are considering its recommendations. "
International experts in DNA forensics say that a paper published online by Nature this week provides a firm alibi for the six medical workers facing the death penalty in Libya. The workers have been charged with deliberately infecting more than 400 children with HIV in 1998.
In the study, an international team led by researchers from Oxford and Rome used the genetic sequences of the viruses isolated from the patients to reconstruct the exact phylogeny, or 'family tree', of the outbreak. Analysing the mutations that accumulated over time allowed the researchers to work out when different outbreaks occurred. They showed that the strain of HIV with which the children had been infected was already present and spreading locally in the Thomas Leitner of Los Alamos National Laboratory in New Mexico has provided forensic HIV evidence in more than 30 such cases over the past 15 years. He describes the de Oliveira paper as "compelling evidence that the outbreak had started before the accused could have started it", a view shared by every expert that Nature contacted (see 'Expert opinion').
Leitner points out that calculating evolutionary timescales is tricky, but that because HIV has such a fast mutation rate, even recent events can be pinpointed quite accurately. "De Oliveira et al. have tested and evaluated the clock and its uncertainty using several methods," he says. "I find their analysis well done and timely, and hope it will affect the judgement in the Libyan court." ■ Declan Butler 
"
The existing epidemiological data are already enough to demonstrate that the accused medical staff cannot be the source of the contamination. De Oliveira's analysis is completely independent, and yields the same conclusion. The court cannot pretend to be impartial if it refuses to hear any competent scientist from abroad.
Michel Milinkovitch, evolutionary geneticist, the Free University of Brussels, Belgium.
They have used state-ofthe-art methods to estimate divergence and dates of events in this outbreak. The analysis shows compelling evidence that the outbreak had started before the accused could have started it.
Thomas Leitner, expert in HIV evolution, Los Alamos National Laboratory, New Mexico.
Expert opinion
The following scientists have all previously testified in court cases involving HIV molecular evidence. They assess the new data.
